Cell and gene therapy manufacturers are increasingly focusing on quality control (QC) as more products enter Phase I and II clinical trials.
https://www.google.com/url?rct=j&sa=t&url=https://www.genengnews.com/topics/bioprocessing/gene-and-cell-therapy-industry-boosts-qc-efforts/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNG8t4Abrbhjq3CyWXnvb-5ZzYEDRw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.